Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

BACKGROUND: Median OS after surgery in curative intent for non-metastasized pancreas cancer ranges under study conditions from 17.9 months to 23.6 months. Tumor recurrence occurs locally, at distant sites (liver, peritoneum, lungs), or both. Observational and autopsy series report local recurrence r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tachezy, Michael, Gebauer, Florian, Petersen, Cordula, Arnold, Dirk, Trepel, Martin, Wegscheider, Karl, Schafhausen, Phillipe, Bockhorn, Maximilian, Izbicki, Jakob Robert, Yekebas, Emre
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057592/
https://ncbi.nlm.nih.gov/pubmed/24906700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-411
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars